Review
Use of enhanced counterpulsation in the treatment of refractory angina pectoris and congestive heart failure
Affiliations
- PMID: 20043608
Item in Clipboard
Review
Use of enhanced counterpulsation in the treatment of refractory angina pectoris and congestive heart failure
Compr Ther.
2009 Fall-Winter.
Abstract
Enhanced external counterpulsation (EECP) is a Food and Drug Administration approved non-pharmacological treatment for angina pectoris refractory to medical management and for use in the treatment of congestive heart failure. EECP improves quality of life, symptoms and exercise duration in these patients.
Similar articles
-
Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure.J Am Coll Cardiol. 2007 Oct 16;50(16):1523-31. doi: 10.1016/j.jacc.2007.07.024. Epub 2007 Oct 1. J Am Coll Cardiol. 2007. PMID: 17936150 Review.
-
Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry).Am J Cardiol. 2006 Jan 1;97(1):17-20. doi: 10.1016/j.amjcard.2005.07.122. Epub 2005 Nov 2. Am J Cardiol. 2006. PMID: 16377276
-
Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure.J Am Coll Cardiol. 2006 Sep 19;48(6):1198-205. doi: 10.1016/j.jacc.2005.10.079. Epub 2006 Aug 28. J Am Coll Cardiol. 2006. PMID: 16979005 Clinical Trial.
-
Enhanced external counterpulsation improves systolic blood pressure in patients with refractory angina.Am Heart J. 2008 Dec;156(6):1217-22. doi: 10.1016/j.ahj.2008.07.024. Epub 2008 Oct 5. Am Heart J. 2008. PMID: 19033023
-
A new treatment modality in heart failure enhanced external counterpulsation (EECP).Cardiol Rev. 2004 Jan-Feb;12(1):15-20. doi: 10.1097/01.crd.0000089949.27512.59. Cardiol Rev. 2004. PMID: 14667258 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical